APA (7th ed.) Citation

JA, W., A, C., S, K., NE, B., G, L., K, A., . . . BS, S. (2022). Endogenous glutamine is rate-limiting for anti-CD3 and anti-CD28 induced CD4+ T-cell proliferation and glycolytic activity under hypoxia and normoxia. The Biochemical journal, 479(11), 1221. https://doi.org/10.1042/BCJ20220144

Chicago Style (17th ed.) Citation

JA, Wik, Chowdhury A, Kolan S, Bastani NE, Li G, Alam K, Grimolizzi F, and Skålhegg BS. "Endogenous Glutamine Is Rate-limiting for Anti-CD3 and Anti-CD28 Induced CD4+ T-cell Proliferation and Glycolytic Activity Under Hypoxia and Normoxia." The Biochemical Journal 479, no. 11 (2022): 1221. https://doi.org/10.1042/BCJ20220144.

MLA (9th ed.) Citation

JA, Wik, et al. "Endogenous Glutamine Is Rate-limiting for Anti-CD3 and Anti-CD28 Induced CD4+ T-cell Proliferation and Glycolytic Activity Under Hypoxia and Normoxia." The Biochemical Journal, vol. 479, no. 11, 2022, p. 1221, https://doi.org/10.1042/BCJ20220144.